Program
VER-01
A development code.
Its studies are mostly in Low Back Pain · Radiculopathy · Chronic Pain, led by Vertanical.
Furthest: phase 3, since Jun 7, 20216 company-led studies, 1 open or runningNext primary completion: Sep 2028 (phase 3)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Vertanical | 61 open or running | phase 3since Jun 7, 2021 | May 24, 2021 | Sep 2028phase 3 · NCT06956014 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- May 24, 2021First study: phase 1 study in Marijuana AbuseFirst studyNCT04930809 · 42 enrolled · Austria
- Jun 7, 2021Phase 3 study in Chronic Non-specific Low Back PainNCT04940741 · 820 enrolled · Germany
- Jun 7, 2021Phase 1 study in Marijuana AbuseNCT04930796 · 18 enrolled · Austria
- Nov 2, 2022Phase 3 study in Chronic Non-specific Low Back PainNCT05610813 · 384 enrolled · Germany
- Jun 12, 2024Phase 2 study in Chronic PainNCT06475001 · 652 enrolled · United Kingdom
- Apr 24, 2025Phase 3 study in Lumbosacral RadiculopathyNCT06956014 · 810 planned · United States
Ahead
- Sep 2028Primary completion: phase 3 study in Lumbosacral RadiculopathyNCT06956014
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 6 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06956014Lumbosacral Radiculopathy · United States | 3 | Recruiting | Sep 2028 | 810 |
| NCT06475001Chronic Pain · United Kingdom | 2 | Completed | Jul 31, 2025 | 652 |
| NCT05610813Chronic Non-specific Low Back Pain · Germany | 3 | Completed | Oct 18, 2024 | 384 |
| NCT04940741Chronic Non-specific Low Back Pain · Germany | 3 | Completed | Mar 26, 2024 | 820 |
| NCT04930796Marijuana Abuse · Austria | 1 | Completed | Nov 17, 2022 | 18 |
| NCT04930809Marijuana Abuse · Austria | 1 | Completed | Jul 4, 2022 | 42 |
How it is read
Names in the registry
- “VER-01”, 6 entries
Codes read as this program: VER01.
Conditions, from the studies’ own filings
- Low Back Pain, 2 studies
- Radiculopathy, 1 study
- Chronic Pain, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.